EndoGastric Solutions EsophyX2 Plus Device with Serosa Fastener and Accessories Part number C02033-01. Label reads in part "EsophyX2 2-LINK Device Qty: (1) Fastener Delivery System ***" Designed for the treatment of Gastroesophageal Reflux Disease (GERD), with erosive and non-erosive esophagitis
Publicado el 24 de abril de 2013 · Inicio del retiro: 4 de febrero de 2013
Resumen
FDA registra el retiro Z-1136-2013 de dispositivos médicos de Clase II, publicado el 24 de abril de 2013 e iniciado el 4 de febrero de 2013. Empresa responsable: Endogastric Solutions Inc; Estado: Finalizado; Cantidad reportada: 190; Lote: Lots 401378, 401392, 401409, and 401416 Additional lots manufactured from 11/26/12 to 12/07/12 had a stop ship issued issued on 11/21/12 and the product was placed in quarantine (it was not distributed). This represents an additional 175 units from a total of 187 units manufactured during this time period. 12 units were used for bench testing. The lot numbers of units in quarantine are 401432, 401434, 401436, and 401441. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
EsophyX2Plus device was not validated under actual or simulated use conditions prior to distributing the product to physicians.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Endogastric Solutions Inc
- Distribuidor
- Nationwide Distribution including NC, VA, WI, TN, KY, IN, FL, MI, IA, IL, TX, LA, AR, HI, CA, NV, OR, and WA,
- Lote
- Lots 401378, 401392, 401409, and 401416 Additional lots manufactured from 11/26/12 to 12/07/12 had a stop ship issued issued on 11/21/12 and the product was placed in quarantine (it was not distributed). This represents an additional 175 units from a total of 187 units manufactured during this time period. 12 units were used for bench testing. The lot numbers of units in quarantine are 401432, 401434, 401436, and 401441.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAEndoGastric Solutions EsophyX2 Device with Serosa Fastener and Accessories. Models R2001 and R2002. Indicated28 de agosto de 2013
- FDAEdwards Lifesciences Crimpers, Model 9100CR26. The Crimpers are used to crimp the transcatheter heart valve24 de abril de 2013
- FDAGE Healthcare, AW Server. Product Usage: . AW Server is a medical software system that allows multiple users24 de abril de 2013
- FDAEdwards Lifesciences Crimpers, Model 9100CR23. The Crimpers are used to crimp the transcatheter heart valve24 de abril de 2013
- FDAOsteoSelect DBM Putty Product Usage: Orthopedic bone filler24 de abril de 2013
- FDAGE Healthcare Muse v7 cardiology information system. Model number 2026443-001: MUSE 7.0 app cd, Model Number24 de abril de 2013
Preguntas sobre este retiro
¿EndoGastric Solutions EsophyX2 Plus Device with Serosa Fastener and Accessories Part number C02033-01. Label reads in part "EsophyX2 2-LINK Device Qty: (1) Fastener Delivery System ***" Designed for the treatment of Gastroesophageal Reflux Disease (GERD), with erosive and non-erosive esophagitis fue retirado del mercado?
Sí. FDA publicó el retiro Z-1136-2013 el 24 de abril de 2013. Peligro reportado: EsophyX2Plus device was not validated under actual or simulated use conditions prior to distributing the product to physicians.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter